Flynn Pharma focuses on the acquisition, development and commercialisation of proprietary products for the secondary healthcare and related markets. Flynn's goal is to be the foremost European provider of specialty products in these targeted and underserved therapeutic categories. Flynn has been structured and financed to pursue a rapid growth strategy in these sectors, offering superior service for our customers and value for our shareholders. Our focus at Flynn Pharma is on prescription pharmaceutical products. Under-promoted brands from other pharmaceutical companies, who often have numerous products that are too small for them, or are no longer of strategic importance. In-licensing of late stage development products from R&D companies in specialist areas.
Stevenage, GB
Size (employees)
35 (est)+3%
Flynn Pharma was founded in 1994 and is headquartered in Stevenage, GB
Report incorrect company information

Flynn Pharma Office Locations

Flynn Pharma has an office in Stevenage
Stevenage, GB (HQ)
Primett Rd
Show all (1)
Report incorrect company information

Flynn Pharma Financials and Metrics

Summary Metrics

Founding Date

Show all financial metrics

Flynn Pharma Financials

Flynn Pharma's revenue was reported to be £51.64 m in FY, 2016 which is a 3.5% increase from the previous period.

Revenue (FY, 2016)

51.6 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

23.6 m

Gross profit margin (FY, 2016), %

GBPFY, 2014FY, 2015FY, 2016


54.1 m49.9 m51.6 m

Revenue growth, %


Cost of goods sold

31.7 m27.7 m28.1 m

Gross profit

22.4 m22.2 m23.6 m
Show all financial metrics
Report incorrect company information